The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer. McCuaig S, Barras D, Mann E, Friedrich M, et al. Clin Cancer Res 2020 May 19. pii: 1078-0432.CCR-19-1086.

Read + Share

Amedeo Smart

Independent Medical Education

McCuaig S, Barras D, Mann E, Friedrich M, et al. The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer. Clin Cancer Res 2020 May 19. pii: 1078-0432.CCR-19-1086.
PMID: 32430479